Insulin inhibits the JNK mediated cell death via upregulation of AKT expression in Schwann cells grown in hyperglycemia
Received date: 13 Feb 2018
Accepted date: 04 Apr 2018
Published date: 28 May 2018
Copyright
BACKGROUND: Schwann cells (SCs) are the glial cells of the peripheral nervous system, which forms a thick insulating structure around the axons. Hyperglycemia is known physiologic conditions in both type I and type II diabetes which causes diabetic neuropathy. But the SC possesses insulin receptors even though glucose uptake is independent of insulin. Since the insulin level is highly altered in diabetes, it is of greater importance to evaluate their role in the Schwann cell survival and death.
METHODS: Schwann cells were isolated from neonatal pups and grown with and without insulin in hyperglycemic medium to mimic diabetic condition for 24 and 48 h. We studied the cell viability using 3 (4,5-dimethylthiazol-2-yl) 2,5-diphenyltetrazolium bromide (MTT) and mitochondrial membrane potential (MMP) assay at different time interval on SCs. We also studied the protein and gene expression of Protein Kinase B (AKT) and Jun N-terminal kinase (JNK), which are greatly involved in cell survival and cell death respectively.
RESULTS: The result shows that, high glucose levels for 48 h decrease the SC viability. Hyperglycemic condition induces the SC death by increasing the JNK expression which in turn reduces the MMP of glial cells. However, insulin administration for SCs grown in high glucose condition can reduce the JNK expression by activating AKT signaling pathway.
CONCLUSION: These observations demonstrate that the proper insulin balance is required for Schwann cells survival in hyperglycemic condition. Therefore, altered insulin signaling can be one of the reasons for demyelination of peripheral neurons in diabetic neuropathy.
Key words: insulin; schwann cells; apoptosis; JNK; AKT; diabetic peripheral neuropathy
Mallahalli S. Manu , Kuruvanthe S. Rachana , Gopal M. Advirao . Insulin inhibits the JNK mediated cell death via upregulation of AKT expression in Schwann cells grown in hyperglycemia[J]. Frontiers in Biology, 2018 , 13(2) : 137 -144 . DOI: 10.1007/s11515-018-1492-4
23 |
Barr R K, Ramirez M J (2006). c-Jun N-terminal kinase (JNK) signaling as a therapeutic target for Alzheimer’s Disease. Front Pharmacol, 6: 1–12
|
1 |
Bhatheja K, Field J (2006). Schwann cells: origins and role in axonal maintenance and regeneration. Int J Biochem Cell Biol, 38(12): 1995–1999
|
2 |
Brockes J P, Fields K L, Raff M C (1979). Studies on cultured rat Schwann cells. I. Establishment of purified populations from cultures of peripheral nerve. Brain Res, 165(1): 105–118
|
3 |
Cai X X, Luo E, Yuan Q (2010). Interaction between Schwann cells and osteoblasts in vitro. Int J Oral Sci, 2(2): 74–81
|
24 |
Campana W M, Darin S J, O'Brien J S (1999). Phosphatidylinositol 3-kinase and Akt protein kinase mediate IGF-I- and prosaptide-induced survival in Schwann cells. J Neurosci Res, 57(3): 332–341
|
4 |
Delaney C L, Cheng H L, Feldman E L (1999). Insulin-like growth factor-I prevents caspase-mediated apoptosis in Schwann cells. J Neurobiol, 41(4): 540–548
|
5 |
Denarier E, Forghani R, Farhadi H F, Dib S, Dionne N, Friedman H C, Lepage P, Hudson T J, Drouin R, Peterson A (2005). Functional organization of a Schwann cell enhancer. J Neurosci, 25(48): 11210–11217
|
6 |
Dhanasekaran D N, Reddy E P (2008). JNK signaling in apoptosis. Oncogene, 27(48): 6245–6251
|
7 |
Jessen K R, Mirsky R (2005). The origin and development of glial cells in peripheral nerves. Nat Rev Neurosci, 6(9): 671–682
|
8 |
Kristiansen M, Hughes R, Patel P, Jacques T S, Clark A R, Ham J (2010). Mkp1 is a c-Jun target gene that antagonizes JNK-dependent apoptosis in sympathetic neurons. J Neurosci, 30(32): 10820–10832
|
9 |
Manning B D, Cantley L C (2007). AKT/PKB signaling: navigating downstream. Cell, 129(7): 1261–1274
|
10 |
Manu M S, Rachana K S, Advirao G M (2017). Altered expression of IRS2 and GRB2 in demyelination of peripheral neurons: Implications in diabetic neuropathy. Neuropeptides, 62: 71–79
|
11 |
Morrison R S, Kinoshita Y, Johnson M D, Ghatan S, Ho J T, Garden G (2002). Neuronal survival and cell death signaling pathways. Adv Exp Med Biol, 513: 41–86
|
12 |
Nakao J, Shinoda J, Nakai Y, Murase S, Uyemura K (1997). Apoptosis regulates the number of Schwann cells at the premyelinating stage. J Neurochem, 68(5): 1853–1862
|
13 |
Okuno S, Saito A, Hayashi T, Chan P H (2004). The c-Jun N-terminal protein kinase signaling pathway mediates Bax activation and subsequent neuronal apoptosis through interaction with Bim after transient focal cerebral ischemia. J Neurosci, 24(36): 7879–7887
|
14 |
Rachana K S, Manu M S, Advirao G M (2016). Insulin influenced expression of myelin proteins in diabetic peripheral neuropathy. Neurosci Lett, 629: 110–115
|
15 |
RohitKumar H G, Asha K R, Raghavan S C, Advi Rao G M (2015). DNA intercalative 4-butylaminopyrimido[4′,5′:4,5]thieno(2,3-b)quinoline induces cell cycle arrest and apoptosis in leukemia cells. Cancer Chemother Pharmacol, 75(6): 1121–1133
|
16 |
Russell J W, Sullivan K A, Windebank A J, Herrmann D N, Feldman E L (1999). Neurons undergo apoptosis in animal and cell culture models of diabetes. Neurobiol Dis, 6(5): 347–363
|
17 |
Shettar A, Muttagi G (2012). Developmental regulation of insulin receptor gene in sciatic nerves and role of insulin on glycoprotein P0 in the Schwann cells. Peptides, 36(1): 46–53
|
18 |
Shetter A R, Muttagi G, Bhadravathi C, Sagar K (2011). Expression and localization of insulin receptors in dissociated primary cultures of rat Schwann cells, Cell Biol Int, 35:299–304
|
19 |
Uranga R M, Katz S, Salvador G A (2013). Enhanced phosphatidylinositol 3-kinase (PI3K)/Akt signaling has pleiotropic targets in hippocampal neurons exposed to iron-induced oxidative stress. J Biol Chem, 288(27): 19773–19784
|
20 |
Vincent A M, Russell J W, Low P, Feldman E L (2004). Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr Rev, 25(4): 612–628
|
21 |
Yarza R, Vela S, Solas M, Ramirez M J (2016). c-Jun N-terminal Kinase (JNK) Signaling as a Therapeutic Target for Alzheimer’s Disease. Front Pharmacol, 6: 321
|
22 |
Zhang L, Yu C, Vasquez F E, Galeva N, Onyango I, Swerdlow R H, Dobrowsky R T (2010). Hyperglycemia alters the schwann cell mitochondrial proteome and decreases coupled respiration in the absence of superoxide production. J Proteome Res, 9(1): 458–471
|
/
〈 | 〉 |